知镜 Cognispect · 医学文献与研究工作台

Pulmonary Hypertension: From Molecular Pathways to Patient Care.

Nardi E, Abbellito GM, Marzano F, Gargiulo P, Perrone-Filardi P, Paolillo S.
Heart failure clinics · 2026-07-01 · PMID 42309621

文献摘要

Pulmonary hypertension (PH) is a heterogeneous condition defined by an increase in mean pulmonary arterial pressure over 20 mm Hg diagnosed through right heart catheterization. Its global prevalence is around 0.6% to 1%. The prognosis used to be poor but nowadays early diagnosis, risk stratification, and a personalized treatment can significantly enhance the prognosis and quality of life of these patients. PH pathophysiology comprises genetic and environmental factors, such as endothelial dysfunction, smooth muscle cell proliferation, inflammation, thrombosis, and right ventricular remodeling. Especially in pulmonary arterial hypertension, treatment options have been radically altered.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。